Table 1. Correlations of FGFR1 expression with clinic-pathological features.
| FGFR1 Negative (%) | FGFR1 Positive (%) | Total | p Value | |
|---|---|---|---|---|
| Grade | 0.136 | |||
| 1 | 144 (90) | 16 (10) | 160 | |
| 2 | 375 (86.0) | 61 (14.0) | 436 | |
| 3 | 422 (84.9) | 75 (15.1) | 497 | |
| FF | 0.073 | |||
| Absence | 700 (87.3) | 101 (12.6) | 801 | |
| Presence | 220 (83.0) | 45 (17.0) | 265 | |
| Total | 920 (86.3) | 146 (13.7) | 1066 | |
| LVI | 0.066 | |||
| Absence | 651 (87.6) | 92 (12.4) | 743 | |
| Presence | 244 (83.3) | 49 (16.7) | 293 | |
| Total | 895 (86.4) | 141 (13.6) | 1036 | |
| pN | 0.042 | |||
| 0 | 481 (88.3) | 64 (11.7) | 545 | |
| 1 | 265 (83.9) | 51 (16.1) | 316 | |
| 2 | 113 (87.6) | 16 (12.4) | 129 | |
| 3 | 68 (79.1) | 18 (20.9) | 86 | |
| Total | 927 (86.2) | 149 (13.8) | 1076 | |
| pT | 0.037 | |||
| 1 | 389 (88.2) | 52 (11.8) | 441 | |
| 2 | 470 (84.5) | 86 (15.5) | 556 | |
| 3 | 48 (82.8) | 10 (17.2) | 58 | |
| 4 | 13 (76.5) | 4 (23.5) | 17 | |
| Total | 920 (85.8) | 152 (14.2) | 1072 | |
| Molecular | < 0.001 | |||
| Lum A | 403 (89.6) | 47 (10.4) | 450 | |
| Lum B | 287 (76.5) | 88 (23.5) | 375 | |
| HER2-OE | 106 (95.5) | 5 (4.5) | 111 | |
| BLBC | 60 (88.2) | 8 (11.8) | 68 | |
| 5NP | 77 (93.9) | 5 (6.1) | 82 | |
| Age | 0.062 | |||
| Mean | 55 (100.5) | 52.3 (95.6) | 54.7 | |
| SD | 12.9 (100.8) | 12 (93.8) | 12.8 | |
| Range | 22–97 | 28–91 | ||
| Tumor size | 0.017 | |||
| Mean | 2.63 | 2.9 | 2.67 | |
| SD | 1.491 | 1.5 | 1.5 | |
| Range | 0.2–13.9 | 0.3–9.5 |
BOLD: statistically significant